Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|May 12, 2023
Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcomeWilliam P Duggan, Manuela Salvucci, Batuhan Kisakol, et al.
Cell Death and Differentiation|June 30, 2026
Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancerEmir Bozkurt, Batuhan Kisakol, Heiko Dussmann, et al.
NAR Genomics and Bioinformatics|April 30, 2021
Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancerMatthew Alderdice, Stephanie G Craig, Matthew P Humphries, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independentJane L Hurwitz, Izabela Stasik, Emma M Kerr, et al.
Cell Death and Differentiation|April 22, 2020
The SCF<sup>Skp2</sup> ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L)Jamie Z Roberts, Caitriona Holohan, Tamas Sessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2013
AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancerPhilip D Dunne, Darragh G McArt, Jaine K Blayney, et al.
Molecular Cancer Therapeutics|July 31, 2016
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung CancerKylie A McLaughlin, Zsuzsanna Nemeth, Conor A Bradley, et al.
Cell Reports|June 17, 2014
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancerSandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
High-Resolution Spatial Proteomics Characterises Colorectal Cancer Consensus Molecular SubtypesBatuhan Kisakol, Anna Sturrock, Sanghee Cho, et al.
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Journal of Molecular Medicine (Berlin, Germany)|May 12, 2023
Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcomeWilliam P Duggan, Manuela Salvucci, Batuhan Kisakol, et al.
Cell Death and Differentiation|June 30, 2026
Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancerEmir Bozkurt, Batuhan Kisakol, Heiko Dussmann, et al.
NAR Genomics and Bioinformatics|April 30, 2021
Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancerMatthew Alderdice, Stephanie G Craig, Matthew P Humphries, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independentJane L Hurwitz, Izabela Stasik, Emma M Kerr, et al.
Cell Death and Differentiation|April 22, 2020
The SCF<sup>Skp2</sup> ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L)Jamie Z Roberts, Caitriona Holohan, Tamas Sessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2013
AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancerPhilip D Dunne, Darragh G McArt, Jaine K Blayney, et al.
Molecular Cancer Therapeutics|July 31, 2016
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung CancerKylie A McLaughlin, Zsuzsanna Nemeth, Conor A Bradley, et al.
Cell Reports|June 17, 2014
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancerSandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
High-Resolution Spatial Proteomics Characterises Colorectal Cancer Consensus Molecular SubtypesBatuhan Kisakol, Anna Sturrock, Sanghee Cho, et al.
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Pageof 12